Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Image

CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial

Journal content Created on 27 Aug 2026 Nature Medicine

Published in

Nature Medicine, Nature Publishing Group

Content

There is no additional content. Please click on the source link to view more information.

Gerhard Krönke

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 33
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement